Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-06-07 4:18 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | RA CAPITAL MANAGEMENT L.P. | 2,253,000 5% | 2,253,000 (New Position) | View |
| 2024-05-28 4:16 pm Purchase | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | BAKER BROS. ADVISORS LP | 9,399,960 19.9% | 1,710,717 (+22.25%) | View |
| 2024-04-18 07:29 am Purchase | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | BAKER BROS. ADVISORS LP | 7,689,243 19.9% | 2,865,645 (+59.41%) | View |
| 2024-02-14 4:08 pm Sale | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Ridgeback Capital Investments L.P. | 844,235 2.2% | -1,420,566 (-62.72%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Paradigm Biocapital Advisors LP | 3,707,001 9.8% | 2,096,336 (+130.15%) | View |
| 2024-02-14 4:07 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Jefferies Financial Group Inc. JEF | 1,948,000 5.165% | 1,948,000 (New Position) | View |
| 2024-02-14 08:37 am Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital LP | 3,490,506 9.25% | 671,461 (+23.82%) | View |
| 2024-02-12 4:10 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | BAKER BROS. ADVISORS LP | 4,823,598 12.8% | 4,823,598 (New Position) | View |
| 2024-02-12 11:59 am Sale | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | JANUS HENDERSON GROUP PLC JHG | 0 0% | -1,503,447 (Position Closed) | View |
| 2023-07-19 6:29 pm Unchanged | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | GSK plc GSK | 1,529,561 4.4% | 0 (Unchanged) | View |
| 2023-02-24 4:54 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Paradigm Biocapital Advisors LP | 1,610,665 5.4% | 1,610,665 (New Position) | View |
| 2023-02-14 4:09 pm Sale | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Point72 Asset Management L.P. | 1,021,168 3.4% | -551,655 (-35.07%) | View |
| 2023-02-14 4:07 pm Sale | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Logos Global Management LP | 1,435,000 4.8% | -115,000 (-7.42%) | View |
| 2023-02-14 4:06 pm Unchanged | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Ridgeback Capital Investments L.P. | 2,264,801 7.6% | 0 (Unchanged) | View |
| 2023-02-14 4:00 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Ridgeback Capital Investments L.P. | 2,264,801 7.6% | 100,000 (+4.62%) | View |
| 2023-02-14 08:31 am Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital LP | 2,819,045 9.5% | 1,322,907 (+88.42%) | View |
| 2023-02-10 10:04 am Sale | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | JANUS HENDERSON GROUP PLC JHG | 1,503,447 5.1% | -191,962 (-11.32%) | View |
| 2022-05-02 4:02 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Logos Global Management LP | 1,550,000 5.2% | 680,000 (+78.16%) | View |
| 2022-03-14 09:29 am Sale | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,408,259 4.8% | -549,702 (-28.08%) | View |
| 2022-02-14 4:40 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Point72 Asset Management L.P. | 1,572,823 5.3% | 135,247 (+9.41%) | View |